why choose us

Clinical Trials Search

Showing 7,830 of 132,963 result(s)
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Status: Completed

Condition: Inherited Bone Marrow Failure Syndrome

Interventions: Imatinib at 100-400 mg PO QD based on arm assignment;dose level

Date: 2023-10-17

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Status: Completed

Condition: Growth Disorders

Interventions: The treatment of children with subcutaneous recombinant human growth hormone (rhGH) is the current gold standard of care for children with diagnosed G

Date: 2023-10-17

Video Vitals and Biomarkers

Status: Completed

Condition: Adults 18 Years and Older (no Other Exclusion Criteria)

Interventions:

Date: 2023-10-17

Resistance Training in Children

Status: Completed

Condition: Healthy

Interventions: Participants will strength train via linear periodization resistance exercise training.

Date: 2023-10-17

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza

Status: Completed

Condition: Influenza

Interventions: Baloxavir marboxil will be administered as oral suspension either as 2 milligrams per kilograms (mg;kg) (if weight less than 20 kg), or 40 mg (if

Date: 2023-10-17

Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Status: Completed

Condition: Intracranial Hemorrhage

Interventions: Determine if fixed-dose 4F-PCC is safe and effective in patients with DOAC-associated ICH when compared to weight-based dosing.

Date: 2023-10-17

Don't Treat Ghosts Anti-MRSA Antibiotics in Osteomyelitis Without Identified MRSA

Status: Completed

Condition: Osteomyelitis

Interventions: chart review to determine the clinical outcomes of patients with osteomyelitis who were placed on definitive anti-MRSA treatment, despite no identifie

Date: 2023-10-17

Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections

Status: Completed

Condition: Streptococcus Pneumoniae

Interventions: To evaluate the effectiveness of short 10 days versus long (?10 days) duration of therapy associated with S. pneumoniae bacteremia.

Date: 2023-10-17

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Status: Completed

Condition: Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Interventions:

Date: 2023-10-17

Ketogenic Diet and Diabetes Demonstration Project

Status: Completed

Condition: Type 2 Diabetes

Interventions: KDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will di

Date: 2023-10-17